
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
-
Your selected country is
United States
- Change country/language
-
Promotions
-
sk-testpage
-
BD Primer Program
-
BD Discovery 2021
-
Reagents
-
DO NOT PUBLISH
-
Reagentes Com Valor Promocional
-
Lunch Box Giveaway
-
EQCプログラム 外部精度管理 施設間精度管理
-
Backbone Reagents Promo
-
Backbone Reagents Promo
-
Classic Dyes
-
Back to Lab
-
End of Year
-
Tcell Backbone Panel Promotion
-
BD Horizon™ Human T Cell Backbone Panel
-
New Lab Promotion
-
Flash Sale
-
BD Panel Design Program
-
Real Dyes Sample Offer
-
BD’s 50 Years of Innovation Research Instrument Promotion
-
BD FACSLyric™ Flow Cytometers 50th Anniversary Promo
-
BD FACSAria™ Customer Loyalty Promotion
-
FlowJo™ Software Promotion
-
BD® Research Cloud Promotion
-
sk-testpage
-
Custom BD® AbSeq
-
Custom AbSeq FAQ Answer 2
-
Custom AbSeq FAQ Answer 3
-
Custom AbSeq FAQ Answer 4
-
Custom AbSeq FAQ Answer 5
-
Custom AbSeq FAQ Answer 6
-
Custom AbSeq FAQ Answer 7
-
Custom AbSeq FAQ Answer 8
-
Custom AbSeq FAQ Answer 9
-
Custom AbSeq FAQ Answer 10
-
Custom AbSeq FAQ Answer 11
-
Custom AbSeq FAQ Answer 12
-
Custom AbSeq FAQ Answer 13
-
Custom AbSeq FAQ Answer 14
-
Custom AbSeq FAQ Answer 15
-
Custom AbSeq FAQ Answer 16
-
Custom AbSeq FAQ Answer 17
-
Custom AbSeq FAQ Answer 18
-
Custom AbSeq FAQ Answer 19
-
Custom AbSeq FAQ Answer 20
-
Custom AbSeq FAQ Answer 2
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
- United States (English)
-
Change country/language
Old Browser
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
Looks like you're visiting us from United States.
Would you like to stay on the current country site or be switched to your country?
Your account has been put on hold due to inactivity. To re-activate, check your account information and make all necessary updates.
BD FACS™ Permeabilizing Solution 2


Regulatory Status Legend
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Product Details
Description
BD FACS™ Permeabilizing Solution 2 (10X) is a premixed concentrate formulated specifically for use in flow cytometry. It is intended for the permeabilization of lymphocyte membranes prior to intracellular immunofluorescence staining with monoclonal antibodies. This formulation is designed for antigen-specific activation applications.
Preparation And Storage
FACS Permeabilizing Solution 2 (10X) is stable for the period shown on the bottle label when stored as directed. Do not use this reagent if discoloration occurs or a precipitate forms. Store 1X solution at room temperature for up to 1 month.
Development References (10)
-
Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus determined by intracellular detection of cytokine expression. J Infec Dis. 2000; 181:859-866. (Biology).
-
Elson LH, Nutman TB, Metcalfe DD, Prussin C. Flow cytometric analysis for cytokine production identifies T helper 1, T helper 2, and T helper 0 cells within the human CD4+ CD27- lymphocyte subpopulation. J Immunol. 1995; 154:4294-4301. (Biology).
-
Komanduri KV, Viswanathan MN, Wieder ED, et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med. 1998; 4:953-956. (Biology).
-
Lee PP, Yee C, Savage PA, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Ned. 1999; 5:677-685. (Biology).
-
Nomura LE, Walker JM, Maecker HT. Optimization of whole blood antigen-specific cytokine assays for CD4+ T cells. Cytometry. 2000; 40:60-68. (Biology).
-
Picker LJ, Singh MK, Zdraveski Z, et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood. 1995; 86:1408-1419. (Biology).
-
Pitcher CJ, Quittner C, Peterson DM, et al. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression.. Nat Med. 1999; 5(5):518-25. (Biology). View Reference
-
Suni MA, Picker LJ, Maino VC. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry.. J Immunol Methods. 1998; 212(1):89-98. (Biology). View Reference
-
Waldrop S, Pitcher C, Peterson D, Maino V, Picker L. Determination of antigen-specific memory/effector CD4 T cell frequencies by flow cytometry. J Clin Invest. 1997; 99:1739-1750. (Biology).
-
Waldrop SL, Davis KA, Maino VC, Picker LJ. Normal human CD4+ memory T cells display broad heterogeneity in their activation threshold for cytokine synthesis.. J Immunol. 1998; 161(10):5284-95. (Biology). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Report a Site Issue
This form is intended to help us improve our website experience. For other support, please visit our Contact Us page.